Pages that link to "Q50430310"
Jump to navigation
Jump to search
The following pages link to anti-retroviral agent (Q50430310):
Displayed 50 items.
- reverse-transcriptase inhibitor (Q421559) (← links)
- entry inhibitor (Q1345259) (← links)
- Julio Montaner (Q1712378) (← links)
- Template:Antiretroviral drug (Q6681246) (← links)
- molecular condom (Q12038536) (← links)
- Task shifting for scale-up of HIV care: evaluation of nurse-centered antiretroviral treatment at rural health centers in Rwanda (Q21034168) (← links)
- The role of social capital in successful adherence to antiretroviral therapy in Africa (Q21034179) (← links)
- Prevention of mother-to-child transmission of HIV: cost-effectiveness of antiretroviral regimens and feeding options in Rwanda (Q21034187) (← links)
- Human breast milk and antiretrovirals dramatically reduce oral HIV-1 transmission in BLT humanized mice (Q21131400) (← links)
- Attrition among human immunodeficiency virus (HIV)- infected patients initiating antiretroviral therapy in China, 2003-2010 (Q21134515) (← links)
- Antiretroviral intensification and valproic acid lack sustained effect on residual HIV-1 viremia or resting CD4 cell infection (Q21142645) (← links)
- Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings (Q21144607) (← links)
- Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice (Q21144657) (← links)
- Provision of antiretroviral treatment in conflict settings: the experience of Médecins Sans Frontières (Q21202765) (← links)
- Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human (Q21245197) (← links)
- Supporting the massive scale-up of antiretroviral therapy: the evolution of PEPFAR-supported treatment facilities in South Africa, 2005-2009 (Q21257287) (← links)
- Potential impact of a free online HIV treatment response prediction system for reducing virological failures and drug costs after antiretroviral therapy failure in a resource-limited setting (Q21284831) (← links)
- Incidence of Tuberculosis among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy in Europe and North America (Q21521430) (← links)
- A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in Uganda (Q21559730) (← links)
- Efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV infected children and adolescents: a systematic review and meta-analysis (Q21999480) (← links)
- AIDS-Related Malignancies: Emerging Challenges in the Era of Highly Active Antiretroviral Therapy (Q22241462) (← links)
- Contribution of Recombination to the Evolution of Human Immunodeficiency Viruses Expressing Resistance to Antiretroviral Treatment (Q22242229) (← links)
- Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review (Q22242638) (← links)
- High multiplicity HIV-1 cell-to-cell transmission from macrophages to CD4 T cells limits antiretroviral efficacy (Q22242698) (← links)
- Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review (Q22242702) (← links)
- Soaring antiretroviral prices, TRIPS and TRIPS flexibilities: a burning issue for antiretroviral treatment scale-up in developing countries (Q22242737) (← links)
- Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities (Q22242738) (← links)
- The impact of host genetics on HIV infection and disease progression in the era of highly active antiretroviral therapy (Q22242809) (← links)
- Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act (Q22242863) (← links)
- Economic and quality of life outcomes of antiretroviral therapy for HIV/AIDS in developing countries: a systematic literature review (Q22248034) (← links)
- Antiretroviral Agents — How Best to Protect Infants from HIV and Save Their Mothers from AIDS (Q22250894) (← links)
- Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy (Q22251085) (← links)
- Antiretroviral adherence in a resource-poor setting (Q22252605) (← links)
- Antiretroviral interventions for preventing breast milk transmission of HIV (Q22252958) (← links)
- Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age (Q24194589) (← links)
- Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy (Q24194925) (← links)
- Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old (Q24197527) (← links)
- Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples (Q24197939) (← links)
- Optimal timing for antiretroviral therapy initiation in patients with HIV infection and concurrent cryptococcal meningitis (Q24200929) (← links)
- Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection (Q24201026) (← links)
- Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals (Q24201955) (← links)
- Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age (Q24202004) (← links)
- Interventions to improve adherence to antiretroviral therapy in children with HIV infection (Q24234320) (← links)
- Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples (Q24234597) (← links)
- Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals (Q24234651) (← links)
- Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy (Q24234853) (← links)
- Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples (Q24234903) (← links)
- Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection (Q24235500) (← links)
- Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals (Q24235724) (← links)
- Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings (Q24235883) (← links)